Moderna is racing towards an important approval. But it may not move the stock higher.

IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-wei

In the most recent trading session, Moderna (MRNA) closed at $59.49, indicating a -3.77% shift from

Moderna is known as a coronavirus vaccine giant, but it's progressively becoming a multi-product com

Moderna doses the first U.S. participant in a phase I study of mRNA-4200, advancing its off-the-shel

Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first U.S. participant in its Phase 1

CAMBRIDGE, MA / ACCESS Newswire / July 16, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the do

Intel stock has more than doubled this year, but JPMorgan has named the chipmaker one of its highest

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Morgan Stanley analyst Matthew Harrison maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and r

RBC Capital analyst Luca Issi maintains Moderna (NASDAQ:MRNA) with a Sector Perform and raises th

B of A Securities analyst Dimple Gosai maintains Moderna (NASDAQ:MRNA) with a Underperform and ra

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Rivian Automotive Inc (RIVN) gained 12.2% after strong Q2 production figures and raised delivery for

Betting against Palantir, Rocket Lab and Strategy was June's smartest move — leveraged short fun

A classic 'flag' pattern has formed on the chart of Moderna (MRNA). This continuation patter

Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its D

Piper Sandler analyst Edward Tenthoff maintains Moderna (NASDAQ:MRNA) with a Overweight and raise

Semiconductors cratered Friday, dragging the stock market lower, while health care and software led

Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected f

Provides broad overview of Company's research and early development programs expected to continu

Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vacc

Major U.S. indexes closed mixed on Tuesday, with the Dow Jones Industrial Average gaining 0.6% to 51

Financials and utilities led Wall Street higher Tuesday as oil slid toward $77 and investors brace f

https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/

Editor’s Note: The future prices of benchmark tracking ETFs and the headline were updated in the sto

DGXX up 19.5% in pre-market trading after increasing the offering program. EZGO, HPAI, MRAM, NVEC,

MRNA revenue hits $389M, beating Wall Street estimates. Despite a Q1 loss, Moderna eyes 10% growth a

FDA court freeze leaves COVID, flu, RSV vaccines in limbo as Kennedy's ACIP overhaul faces legal

Trump, in January, said "inflation has been defeated." Wall Street is now bracing for a 0.9%

Wall Street analysts changed outlook on top names. See complete view of rating changes, including up

WTI crude oil fell 2% after Iran's President signaled readiness to end war. Nasdaq QQQ surged 3.

Medicare Chief Chris Klomp is optimistic for strong outcome in the search of CDC leader in midst of

A federal judge warns that RFK Jr.'s vaccine overhaul likely violates federal law. Discover the

FDA biologics chief Vinay Prasad will leave in April, lifting biotech stocks such as uniQure, Capric

uniQure (QURE) stock surges following news of CBER director Vinay Prasad's exit. See why the mar

Wall Street mounted a relief rally Wednesday as traders weighed reports of potential U.S.-Iran diplo

Dow falls 100 pts, Latham Group Inc (SWIM) rises 25.7%, Babcock & Wilcox Enterprises Inc (BW) ga

Ten large-cap stocks led last week's gains, driven by upbeat earnings, guidance, buybacks, and k

The Supreme Court stikes down Trump's IEEPA tariffs. Trump replies with a new 10% global levy un

Moderna's mRNA-1010 flu vaccine clears FDA review, with stock rising ahead of major approvals.

Moderna beat fourth-quarter sales expectations and forecast growth for 2026, but an FDA refusal on i

U.S. inflation cooled to 2.4% in January, below expectations and the lowest since May 2025, boosting

Blowout Jobs Report